What is CoQ10?
CoQ10 is the electron shuttle of the mitochondrial inner membrane — it carries electrons from Complexes I and II to Complex III in the electron transport chain. Without adequate CoQ10, the ETC cannot function efficiently and ATP production suffers. It is also a potent lipid-soluble antioxidant that protects mitochondrial membranes from oxidative damage. CoQ10 levels decline progressively with age — approximately 50% between ages 20 and 80 — and are specifically and substantially depleted by statin medications, the most widely prescribed drug class.
The statin depletion context is why CoQ10 matters to a broader-than-expected audience. Statins inhibit HMG-CoA reductase — the rate-limiting enzyme in cholesterol synthesis. But this same enzyme is rate-limiting in the mevalonate pathway that produces CoQ10. Statins therefore reduce CoQ10 synthesis alongside cholesterol. Statin-induced myopathy — muscle pain, weakness, and fatigue affecting 5-20% of statin users — is hypothesised to be partly driven by this CoQ10 depletion in muscle cells.
The cardiovascular evidence is CoQ10’s strongest clinical area. The landmark Q-SYMBIO trial (2014) showed CoQ10 300 mg/day in heart failure patients reduced major cardiovascular events by 42% versus placebo over 2 years — a dramatic effect size that made CoQ10 the first supplement to significantly improve outcomes in chronic heart failure. Q-SYMBIO remains one of the most important cardiovascular supplement trials ever conducted.
For the mitochondrial longevity stack: CoQ10 addresses the electron carrier layer — the actual shuttle that moves electrons through the ETC. This is distinct from and complementary to SS-31 (which stabilises cardiolipin in the inner membrane), MOTS-c (which activates AMPK and mitochondrial gene expression), and NAD+ (which fuels the ETC dehydrogenases). Each addresses a different layer of mitochondrial function.
How it works
ETC Electron Carrier — Complex I/II to Complex III
CoQ10 shuttles electrons from NADH dehydrogenase (Complex I) and succinate dehydrogenase (Complex II) to the cytochrome bc1 complex (Complex III). This electron shuttling is essential for maintaining the proton gradient across the inner mitochondrial membrane that drives ATP synthase. Without adequate CoQ10, electron flow through the ETC is bottlenecked, the proton gradient falls, and ATP production decreases. In energy-demanding tissues like the heart — which produces approximately 6 kg of ATP daily — CoQ10 deficiency has immediate functional consequences.
Lipid Antioxidant — Membrane Protection
In its reduced form (ubiquinol), CoQ10 is a potent lipid-soluble antioxidant that donates electrons to neutralise lipid peroxyl radicals in the mitochondrial inner membrane. This antioxidant function protects the membrane lipids (particularly cardiolipin) from oxidative degradation. Ubiquinol also regenerates vitamins C and E after oxidation, contributing to the broader cellular antioxidant network.
Why Ubiquinol Is Preferred Over 40
Standard CoQ10 supplements contain ubiquinone (the oxidised form), which must be converted to ubiquinol (the active reduced form) by NQO1 enzyme activity in the gut and liver. NQO1 activity declines with age and is reduced by statin medications. For adults over 40, statin users, or people with compromised conversion, ubiquinol supplements provide the active form directly — bypassing the conversion step. Pharmacokinetic studies consistently show ubiquinol achieves higher plasma CoQ10 levels than equivalent ubiquinone doses in older adults.
What the research shows
What the community reports
The CoQ10/ubiquinol community splits between statin users managing side effects and biohackers building mitochondrial stacks.
Common misconceptions
"Standard CoQ10 capsules are as good as ubiquinol."
For adults under 40 with healthy NQO1 conversion activity, ubiquinone converts efficiently and the forms are equivalent. For adults over 40, statin users, or those with impaired conversion, ubiquinol provides significantly higher plasma levels at equivalent doses. Practical guidance: under 40, either form is fine; over 40 or on statins, ubiquinol is specifically preferred.
"CoQ10 cures heart failure."
Q-SYMBIO showed a 42% reduction in MACE in heart failure patients on CoQ10 — a remarkable result, but CoQ10 was an adjunct to standard heart failure medications, not a replacement. Patients still had heart failure and still required their standard treatment. CoQ10 is a meaningful adjunct with impressive evidence, not a standalone therapy.
Open PepperLedger to track your CoQ10 protocol →
Free to join. No credit card. Ask the Coach about CoQ10 dosing for statin users, heart health, and the mitochondrial stack.
Free to join · No credit card · 23-day Pro trial included